{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:20:34Z","timestamp":1765808434605,"version":"3.38.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nmd.2024.105272","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T22:54:25Z","timestamp":1734735265000},"page":"105272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The relationship between patient-reported and clinician-assessed outcome measures in Inclusion body myositis - insights from a retrospective cohort study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-2329","authenticated-orcid":false,"given":"Madeline","family":"Schopp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-781X","authenticated-orcid":false,"given":"Kelly","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Hird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Althea","family":"Doverty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annik","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Brusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrilee","family":"Needham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2024.105272_bib0001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1329197","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2012","journal-title":"Semin Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0002","first-page":"69","article-title":"A double-blinded randomised controlled trial to establish whether testosterone treatment combined with exercise improves muscle strength and function and quality of life in men affected by inclusion body myositis","volume":"3","author":"Connor","year":"2020","journal-title":"Tasman Med J"},{"key":"10.1016\/j.nmd.2024.105272_bib0003","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1153789","article-title":"Uncovering the significance of expanded CD8(+) large granular lymphocytes in inclusion body myositis: insights into T cell phenotype and functional alterations, and disease severity","volume":"14","author":"McLeish","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nmd.2024.105272_bib0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nmd.2024.105272_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1020113","article-title":"Inclusion body myositis: update on the diagnostic and therapeutic landscape","volume":"13","author":"Naddaf","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0007","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mus.27716","article-title":"Atypical presentations of inclusion body myositis: clinical characteristics and long-term outcomes","volume":"66","author":"Alamr","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.105272_bib0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.26859","article-title":"Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups","volume":"62","author":"Oldroyd","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.105272_bib0009","doi-asserted-by":"crossref","first-page":"404","DOI":"10.55563\/clinexprheumatol\/0q2voe","article-title":"Measuring change in inclusion body myositis: clinical assessments versus imaging","volume":"40","author":"Alfano","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nmd.2024.105272_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20532","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.nmd.2024.105272_bib0011","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nmd.2024.105272_bib0012","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mus.20958","article-title":"Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity","volume":"37","author":"Jackson","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.105272_bib0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004150050005","article-title":"High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study","volume":"247","author":"Walter","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0014","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.semarthrit.2020.06.006","article-title":"Assessing the content validity of patient-reported outcome measures in adult myositis: a report from the OMERACT myositis working group","volume":"50","author":"Esfandiary","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nmd.2024.105272_bib0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp-2020-325141","article-title":"Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis","volume":"92","author":"Sangha","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2024.105272_bib0016","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1002\/mus.25603","article-title":"Physical function and muscle strength in sporadic inclusion body myositis","volume":"56","author":"Jorgensen","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.105272_bib0017","doi-asserted-by":"crossref","first-page":"1192770","DOI":"10.3389\/fphar.2023.1192770","article-title":"How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action","volume":"14","author":"Janssens","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nmd.2024.105272_bib0018","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC international workshop: inclusion body myositis, 2-4 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.105272_bib0019","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.43.5.876","article-title":"Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin","volume":"43","author":"Soueidan","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.105272_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-8-26","article-title":"Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial","volume":"8","author":"Walter","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2024.105272_bib0021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09638288.2017.1398787","article-title":"Construct validity of the eating assessment tool (EAT-10)","volume":"41","author":"Wilmskoetter","year":"2019","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.nmd.2024.105272_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/000348940811701210","article-title":"Validity and reliability of the Eating Assessment Tool (EAT-10)","volume":"117","author":"Belafsky","year":"2008","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.nmd.2024.105272_bib0023","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.nmd.2020.08.358","article-title":"Optimizing hand-function patient outcome measures for inclusion body myositis","volume":"30","author":"Lin","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.105272_bib0024","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0363-5023(84)80146-X","article-title":"Reliability and validity of grip and pinch strength evaluations","volume":"9","author":"Mathiowetz","year":"1984","journal-title":"J. Hand Surg. Am."},{"key":"10.1016\/j.nmd.2024.105272_bib0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nmd.2024.105272_bib0026","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.nmd.2013.11.012","article-title":"The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis","volume":"24","author":"Alfano","year":"2014","journal-title":"Neuromuscul Dis"},{"year":"2023","series-title":"IBM spss statistics for macintosh, version 29.0","key":"10.1016\/j.nmd.2024.105272_bib0027"},{"key":"10.1016\/j.nmd.2024.105272_bib0028","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.nmd.2022.08.005","article-title":"Correlations of disease severity outcome measures in inclusion body myositis","volume":"32","author":"Goyal","year":"2022","journal-title":"Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.105272_bib0029","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jvim.15458","article-title":"Why measuring outcomes is important in health care","volume":"33","author":"Pantaleon","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.nmd.2024.105272_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.nmd.2024.105272_bib0031","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1017\/S1047951114002728","article-title":"The impact of illness perceptions and disease severity on quality of life in congenital heart disease","volume":"26","author":"O'Donovan","year":"2016","journal-title":"Cardiol Young"},{"key":"10.1016\/j.nmd.2024.105272_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2024.105272_bib0033","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0277-9536(98)00411-0","article-title":"The disability paradox: high quality of life against all odds","volume":"48","author":"Albrecht","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.nmd.2024.105272_bib0034","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp-2020-325141","article-title":"Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis","volume":"92","author":"Sangha","year":"2021","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2024.105272_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2013.02.010","article-title":"Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials","volume":"23","author":"Cortese","year":"2013","journal-title":"Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.105272_bib0036","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","article-title":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Hanna","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1212\/WNL.0000000000002332","article-title":"Two- and 6-minute walk tests assess walking capability equally in neuromuscular diseases","volume":"86","author":"Andersen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.105272_bib0038","first-page":"441","article-title":"Old muscle, new tricks: a clinician perspective on sarcopenia and where to next","volume":"36","author":"Schutze","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2024.105272_bib0039","doi-asserted-by":"crossref","first-page":"101761","DOI":"10.1016\/j.berh.2022.101761","article-title":"Inclusion body myositis: the interplay between ageing, muscle degeneration and autoimmunity","volume":"36","author":"McLeish","year":"2022","journal-title":"Best Prac Res Clin Rheumatol"},{"key":"10.1016\/j.nmd.2024.105272_bib0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/lary.30043","article-title":"Discriminant ability of the eating assessment tool-10 to detect swallowing safety and efficiency impairments","volume":"132","author":"Donohue","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.nmd.2024.105272_bib0041","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00455-021-10244-0","article-title":"Correlation between EAT-10 and aspiration risk differs by dysphagia etiology","volume":"37","author":"Bartlett","year":"2022","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2024.105272_bib0042","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5056\/jnm16165","article-title":"The ability of the eating assessment tool-10 to detect aspiration in patients with neurological disorders","volume":"23","author":"Arslan","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.nmd.2024.105272_bib0043","series-title":"Still seeking the holy grail of outcome measures in inclusion body myositis","first-page":"802","author":"Hogrel","year":"2021"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624017681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624017681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:46:25Z","timestamp":1741837585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624017681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S0960896624017681"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.105272","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between patient-reported and clinician-assessed outcome measures in Inclusion body myositis - insights from a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.105272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105272"}}